arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

LABCORP HOLDINGS INC.

LH
$319.08 ▲ +2.49 (+0.79%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
19 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

LABCORP HOLDINGS INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $26.5B
Dividend Yield 0.90%
Revenue Growth 7.2%
Op. Margin 9.9%
ROIC 8.0%
FCF / Share $14.50
Trailing P/E 30.3x
Price / Book 3.0x
FCF Yield 4.5%
Debt / Equity 0.59
info Valuation on last close. End-of-day price, Aug 7, 2026.

19-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$13.95B
↑ +7.2%
Net Income Profit after all expenses
$876.50M
↑ +17.5%
Operating Margin Operating profit as % of sales
9.9%
↑ +18.8% 56th
FCF / Share Free cash flow per share
$14.50
↑ +11.0%
Long-Term Debt Long-term obligations
$5.08B
↓ -4.6%

Health Breakdown

Profitability
56
Returns
68
Financial Health
61
Cash Quality
78

Dividend History

Dividend / share · sourced from SEC filings
$2.88 Latest / share
+0.0% YoY
+0.0% 3-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 71 quarters